Delivery Order SPE2DR25D9238-SPE2DR26FRRF4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,089.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for supply of VABYSMO 6 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a delivery order valued at $44,651.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml vials. The delivery order, issued on December 9, 2025, is structured as a firm fixed-price contract with an ultimate completion date of December 31, 2025. This award carries no set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $1,488.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 17, 2025, for VABYSMO 6 mg/0.05 ml syringes valued at $5,966.88 with a firm fixed-price structure. The delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, utilizes firm fixed-price pricing with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,966.88 by the Defense Logistics Agency on August 6, 2025, for the supply of Vabysmo 6 mg/0.05 ml syringes. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,983.44 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes (0.05 mL) with an ultimate completion date of June 24, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement of this pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- The Department of Defense Medical Supply Chain awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $11,933.76 for Vabysmo 6 mg/0.05 ml syringes. The award was made on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete openly based on its established...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $30.4K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of VABYSMO 6 MG/0.05 ML syringes. This delivery order was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- SPE2DR25D9238Indefinite Delivery Contract
- SPE2DR25D9238-SPE2DR26FRRF4Delivery Order
The Defense Logistics Agency issued a $6,089.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 mL syringes. The delivery order, awarded on December 4, 2025, with an ultimate completion date of December 26, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and maintains a comprehensive product portfolio spanning branded and generic pharmaceuticals, biologics, vaccines, and specialty medical products. The prime contractor holds a primary indefinite delivery contract (SPE2DR) under the PPV-G GEN V program with a $499.999 billion ceiling value extending through December 31, 2036, positioning the company as a critical supplier within the federal pharmaceutical supply chain. No subcontractors are identified on this delivery order, with all funding provided directly by the Defense Logistics Agency's Medical Supply Chain division.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 12/3/25 |